149 related articles for article (PubMed ID: 15715728)
21. Antifungal alternatives for invasive candidiasis refractory to caspofungin in liver transplant recipients: A report of two cases.
Choukroun G; Thirion M; Lortholary O; Scatton O; Conti F; Calmus Y; Paugam A; Pène F
Transplantation; 2006 Nov; 82(10):1385-6. PubMed ID: 17130792
[No Abstract] [Full Text] [Related]
22. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
[TBL] [Abstract][Full Text] [Related]
23. Successful initial treatment with caspofungin alone for hepatosplenic candidiasis in a patient with acute myeloblastic leukemia.
Altintas A; Ayyildiz O; Isikdogan A; Atay E; Kaplan MA
Saudi Med J; 2006 Sep; 27(9):1423-4. PubMed ID: 16951789
[No Abstract] [Full Text] [Related]
24. Echinocandins: ask not what they can do for esophageal candidiasis--ask what studies of esophageal candidiasis can do for them.
Darouiche RO
Clin Infect Dis; 2004 Sep; 39(6):850-2. PubMed ID: 15472818
[No Abstract] [Full Text] [Related]
25. Caspofungin--a new therapeutic option for oropharyngeal candidiasis.
Garbino J
Clin Microbiol Infect; 2004 Mar; 10(3):187-9. PubMed ID: 15008939
[TBL] [Abstract][Full Text] [Related]
26. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
[TBL] [Abstract][Full Text] [Related]
27. Caspofungin for refractory candidemia in neonates.
Manzar S; Kamat M; Pyati S
Pediatr Infect Dis J; 2006 Mar; 25(3):282-3. PubMed ID: 16511405
[No Abstract] [Full Text] [Related]
28. Successful treatment of azole-resistant chronic mucocutaneous candidosis with caspofungin.
Jayasinghe M; Schmidt S; Walker B; Röcken M; Schaller M
Acta Derm Venereol; 2006; 86(6):563-4. PubMed ID: 17106615
[No Abstract] [Full Text] [Related]
29. Possible hepatosplenic candidiasis treated with liposomal amphotericin B and caspofungin combination.
Arda B; Soyer N; Sipahi OR; Hüdaverdi O; Tasbakan MI; Saydam G; Tombuloglu M
J Infect; 2006 May; 52(5):387-8. PubMed ID: 16181678
[No Abstract] [Full Text] [Related]
30. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
[TBL] [Abstract][Full Text] [Related]
31. Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
Agnelli C; Guinea J; Valerio M; Escribano P; Bouza E; Muñoz P
Rev Esp Quimioter; 2019 Aug; 32(4):395-397. PubMed ID: 31327188
[No Abstract] [Full Text] [Related]
32. Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
Ninomiya M; Mikamo H; Tanaka K; Watanabe K; Tamaya T
J Antimicrob Chemother; 2005 Apr; 55(4):587-90. PubMed ID: 15728144
[TBL] [Abstract][Full Text] [Related]
33. Need for early antifungal treatment confirmed in experimental disseminated Candida albicans infection.
MacCallum DM; Odds FC
Antimicrob Agents Chemother; 2004 Dec; 48(12):4911-4. PubMed ID: 15561880
[TBL] [Abstract][Full Text] [Related]
34. Recombinant tissue plasminogen activator treatment for intracardiac vegetation in a very low birth weight infant.
Ozdemir AA
Arch Argent Pediatr; 2017 Oct; 115(5):e307-e310. PubMed ID: 28895709
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of refractory chronic disseminated candidiasis after prolonged administration of caspofungin in a child with acute myeloid leukemia.
Kontny U; Walsh TJ; Rossler J; Uhl M; Niemeyer CM
Pediatr Blood Cancer; 2007 Sep; 49(3):360-2. PubMed ID: 16444677
[TBL] [Abstract][Full Text] [Related]
36. Caspofungin in the treatment of oropharyngeal candidiasis.
Garbino J; Lew D; Hirschel B; Rohner P
Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
[TBL] [Abstract][Full Text] [Related]
37. Candida endocarditis: role of new antifungal agents.
Talarmin JP; Boutoille D; Tattevin P; Abgueguen P; Ansart S; Roblot F; Raffi F
Mycoses; 2009 Jan; 52(1):60-6. PubMed ID: 18498304
[TBL] [Abstract][Full Text] [Related]
38. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
40. Native valve Aspergillus endocarditis in two patients with aplastic anaemia.
Petrikkos GL; Skiada A; Samonis G; Mavroudis D; Daikos GL
Scand J Infect Dis; 2006; 38(10):916-20. PubMed ID: 17008238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
